A Multiplex Network Control Method for Identifying Personalized Cancer Driver Genes

被引:0
作者
Zhang, Tong [1 ,2 ]
Zhang, Shao-Wu [1 ]
Li, Yan [1 ]
Xie, Ming-Yu [1 ]
机构
[1] Northwestern Polytech Univ, Minist Educ, Sch Automat, Key Lab Informat Fus Technol, Xian 710072, Peoples R China
[2] Pingdingshan Univ, Sch Elect & Mech Engn, Pingdingshan 467000, Peoples R China
基金
中国国家自然科学基金;
关键词
multiplex biomolecular networks; multiplex network control; personalized cancer driver genes; sample-specific multiplex network; minimum vertex cover set; SOMATIC MUTATIONS; GENOME; PATHWAYS;
D O I
10.16476/j.pibb.2023.0392
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective Inferring cancer driver genes, especially rare or sample-specific cancer driver genes, is crucial for precision oncology. Considering the high inter-tumor heterogeneity, a few recent methods attempt to reveal cancer driver genes at the individual level. However, most of these methods generally integrate multi-omics data into a single biomolecular network (e.g., gene regulatory network or protein-protein interaction network) to identify cancer driver genes, which results in missing important interactions highlighted in different networks. Thus, the development of a multiplex network method is imperative in order to integrate the interactions of different biomolecular networks and facilitate the identification of cancer driver genes.Methods A multiplex network control method called Personalized cancer Driver Genes with Multiplex biomolecular Networks (PDGMN) was proposed. Firstly, the sample-specific multiplex network, which contains protein-protein interaction layer and gene-gene association layer, was constructed based on gene expression data. Subsequently, somatic mutation data was integrated to weight the nodes in the sample-specific multiplex network. Finally, a weighted minimum vertex cover set identification algorithm was designed to find the optimal set of driver nodes, facilitating the identification of personalized cancer driver genes.Results The results derived from three TCGA cancer datasets indicate that PDGMN outperforms other existing methods in identifying personalized cancer driver genes, and it can effectively identify the rare driver genes in individual patients. Particularly, the experimental results indicate that PDGMN can capture the unique characteristics of different biomolecular networks to improve cancer driver gene identification.Conclusion PDGMN can effectively identify personalized cancer driver genes and broaden our understanding of cancer driver gene identification from a multiplex network perspective. The source code and datasets used in this work are available at https://github.com/NWPU-903PR/PDGMN.
引用
收藏
页码:1711 / 1726
页数:16
相关论文
共 60 条
  • [1] powerlaw: A Python']Python Package for Analysis of Heavy-Tailed Distributions
    Alstott, Jeff
    Bullmore, Edward T.
    Plenz, Dietmar
    [J]. PLOS ONE, 2014, 9 (01):
  • [2] Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.07.034, 10.1016/j.cell.2018.02.060]
  • [3] DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer
    Bashashati, Ali
    Haffari, Gholamreza
    Ding, Jiarui
    Ha, Gavin
    Lui, Kenneth
    Rosner, Jamie
    Huntsman, David G.
    Caldas, Carlos
    Aparicio, Samuel A.
    Shah, Sohrab P.
    [J]. GENOME BIOLOGY, 2012, 13 (12): : R124
  • [4] Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles
    Bertrand, Denis
    Chng, Kern Rei
    Sherbaf, Faranak Ghazi
    Kiesel, Anja
    Chia, Burton K. H.
    Sia, Yee Yen
    Huang, Sharon K.
    Hoon, Dave S. B.
    Liu, Edison T.
    Hillmer, Axel
    Nagarajan, Niranjan
    [J]. NUCLEIC ACIDS RESEARCH, 2015, 43 (07)
  • [5] Pan-cancer analysis of whole genomes
    Campbell, Peter J.
    Getz, Gad
    Korbel, Jan O.
    Stuart, Joshua M.
    Jennings, Jennifer L.
    Stein, Lincoln D.
    Perry, Marc D.
    Nahal-Bose, Hardeep K.
    Ouellette, B. F. Francis
    Li, Constance H.
    Rheinbay, Esther
    Nielsen, G. Petur
    Sgroi, Dennis C.
    Wu, Chin-Lee
    Faquin, William C.
    Deshpande, Vikram
    Boutros, Paul C.
    Lazar, Alexander J.
    Hoadley, Katherine A.
    Louis, David N.
    Dursi, L. Jonathan
    Yung, Christina K.
    Bailey, Matthew H.
    Saksena, Gordon
    Raine, Keiran M.
    Buchhalter, Ivo
    Kleinheinz, Kortine
    Schlesner, Matthias
    Zhang, Junjun
    Wang, Wenyi
    Wheeler, David A.
    Ding, Li
    Simpson, Jared T.
    O'Connor, Brian D.
    Yakneen, Sergei
    Ellrott, Kyle
    Miyoshi, Naoki
    Butler, Adam P.
    Royo, Romina
    Shorser, Solomon, I
    Vazquez, Miguel
    Rausch, Tobias
    Tiao, Grace
    Waszak, Sebastian M.
    Rodriguez-Martin, Bernardo
    Shringarpure, Suyash
    Wu, Dai-Ying
    Demidov, German M.
    Delaneau, Olivier
    Hayashi, Shuto
    [J]. NATURE, 2020, 578 (7793) : 82 - +
  • [6] Chakravarty D, 2017, JCO PRECIS ONCOL, V1
  • [7] Network-based approach to prediction and population-based validation of in silico drug repurposing
    Cheng, Feixiong
    Desai, Rishi J.
    Handy, Diane E.
    Wang, Ruisheng
    Schneeweiss, Sebastian
    Barabasi, Albert-Laszlo
    Loscalzo, Joseph
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [8] Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes
    Cheng, Feixiong
    Zhao, Junfei
    Zhao, Zhongming
    [J]. BRIEFINGS IN BIOINFORMATICS, 2016, 17 (04) : 642 - 656
  • [9] Cell-specific network constructed by single-cell RNA sequencing data
    Dai, Hao
    Li, Lin
    Zeng, Tao
    Chen, Luonan
    [J]. NUCLEIC ACIDS RESEARCH, 2019, 47 (11)
  • [10] PRODIGY: personalized prioritization of driver genes
    Dinstag, Gal
    Shamir, Ron
    [J]. BIOINFORMATICS, 2020, 36 (06) : 1831 - 1839